Lasa Supergeneri

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
8.68
-0.33 (-3.66%)
BSENSE

Feb 12

BSE+NSE Vol: 16.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.68",
    "chg": -0.33,
    "chgp": "-3.66%",
    "dir": -1,
    "prev_price": "9.01",
    "mcapval": "45.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE670X01014",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "16.86 k",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Lasa Supergenerics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lasa-supergenerics-ltd-3821301",
        "imagepath": "",
        "date": "2026-02-04 23:17:49",
        "description": "Lasa Supergenerics Ltd is scheduled to declare its results on 13 February 2026...."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-3820332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LasaSupergeneri_mojoScore_3820332.png",
        "date": "2026-02-04 10:11:15",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Lasa Supergenerics Ltd’s Volatile Week: -0.43% Amid Circuit Hits and Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltds-volatile-week--043-amid-circuit-hits-and-mixed-market-signals-3803298",
        "imagepath": "",
        "date": "2026-01-24 13:01:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 21:</strong> Stock hits upper circuit amid strong buying pressure</p>\n                    <p><strong>Jan 22:</strong> Another upper circuit hit with increased delivery volumes</p>\n                    <p><strong>Jan 23:</strong> Sharp decline to lower circuit amid heavy selling pressure</p>\n                    <p><strong>Week Close:</strong> Rs.9.35 (-0.43%) vs Sensex -3.31%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.9.39</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.9.35..."
      },
      {
        "title": "Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3801827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LasaSupergeneri_stocks_hitting_lower_circuit_3801827.png",
        "date": "2026-01-23 13:00:14",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 23 Jan 2026, hitting its lower circuit limit and registering a maximum daily loss of 2.55%. The stock’s sharp decline reflects mounting investor concerns amid deteriorating technical and fundamental indicators."
      },
      {
        "title": "Lasa Supergenerics Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3800150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LasaSupergeneri_stocks_hitting_upper_circuit_3800150.png",
        "date": "2026-01-22 11:00:15",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in buying interest on 22 Jan 2026, hitting its upper circuit price limit. Despite recent underperformance relative to its sector and broader market indices, the stock’s sudden rally underscores intense demand and a potential shift in investor sentiment."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-3799897",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LasaSupergeneri_mojoScore_3799897.png",
        "date": "2026-01-22 10:10:41",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3791981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LasaSupergeneri_stocks_hitting_lower_circuit_3791981.png",
        "date": "2026-01-14 11:00:08",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 14 Jan 2026, hitting its lower circuit limit amid intense selling pressure. The stock closed at ₹9.43, down 4.46% on the day, marking its fifth consecutive day of losses and signalling mounting investor concerns."
      },
      {
        "title": "Lasa Supergenerics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3791062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LasaSupergeneri_stocks_hitting_lower_circuit_3791062.png",
        "date": "2026-01-12 13:00:24",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 12 Jan 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The share price plunged by nearly 5%, marking its maximum daily loss and signalling panic selling among investors amid subdued market sentiment."
      },
      {
        "title": "Lasa Supergenerics Ltd Falls 3.53%: 2 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-falls-353-2-key-events-shaping-the-week-3788245",
        "imagepath": "",
        "date": "2026-01-10 13:01:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Jan:</strong> Stock opens at Rs.10.92, down 3.62%</p>\n                    <p><strong>7 Jan:</strong> Hits upper circuit amid strong buying pressure</p>\n                    <p><strong>9 Jan:</strong> Hits lower circuit amid heavy selling pressure</p>\n                    <p><strong>9 Jan:</strong> Week closes at Rs.10.93, down 3.53%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.11.33</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.10.93</div><div class=\"stat-change negative\">-3.5..."
      }
    ],
    "total": 217,
    "sid": "1002834",
    "stock_news_url": "https://www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for For The Quarter Ended December 31 2025",
      "datetime": "03-Feb-2026",
      "details": "Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday February 13 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended December 31 2025. 2. To discuss any other matter with the permission of the Chairperson.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "15-Jan-2026",
      "details": "Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. January 02 2026 1. Appointment Of Mr. Ganesh Suresh Potdar As An Additional Director In Capacity Of (Executive Director) And Occupier Of All Units Of The Company.",
      "datetime": "02-Jan-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . January 02 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(13 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Lasa Supergenerics Ltd’s Volatile Week: -0.43% Amid Circuit Hits and Mixed Market Signals

2026-01-24 13:01:40

Key Events This Week

Jan 21: Stock hits upper circuit amid strong buying pressure

Jan 22: Another upper circuit hit with increased delivery volumes

Jan 23: Sharp decline to lower circuit amid heavy selling pressure

Week Close: Rs.9.35 (-0.43%) vs Sensex -3.31%

stock-recommendationAnnouncement

Board Meeting Intimation for For The Quarter Ended December 31 2025

03-Feb-2026 | Source : BSE

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday February 13 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended December 31 2025. 2. To discuss any other matter with the permission of the Chairperson.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

15-Jan-2026 | Source : BSE

Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018

Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. January 02 2026 1. Appointment Of Mr. Ganesh Suresh Potdar As An Additional Director In Capacity Of (Executive Director) And Occupier Of All Units Of The Company.

02-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . January 02 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(13 Feb 2026)

stock-summary
DIVIDEND

Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available